GLOW (GHK-Cu + TB-500 + BPC-157) vs. KLOW (BPC-157 + GHK-Cu + TB-500 + KPV)
Head-to-head comparison based on the profiles in the PepCycle library.
| Attribute | GLOW (GHK-Cu + TB-500 + BPC-157) | KLOW (BPC-157 + GHK-Cu + TB-500 + KPV) |
|---|---|---|
| Class | Regenerative Stack | Regenerative Stack |
| Description | The GLOW stack is a pre-mixed regenerative beauty and healing blend combining three powerful repair peptides in a single vial. GHK-Cu (Copper Peptide) drives collagen remodeling, elastin production, and deep skin renewal at the gene expression level. TB-500 (Thymosin Beta-4) promotes systemic tissue repair through cell migration, angiogenesis, and anti-inflammatory signaling. BPC-157 (Body Protection Compound) accelerates wound healing, protects gut mucosa, and enhances blood vessel formation. Together, they create a synergistic repair cascade targeting skin aging, tissue damage, and chronic inflammation from multiple pathways simultaneously. | The KLOW stack is an advanced pre-mixed anti-inflammatory and regenerative quad-blend that builds on the GLOW formula by adding KPV, a potent alpha-MSH-derived anti-inflammatory tripeptide. This comprehensive single-vial formulation targets systemic inflammation, autoimmune conditions, gut healing, and skin rejuvenation. BPC-157 provides tissue protection and gut repair, GHK-Cu drives deep collagen remodeling, TB-500 enables cell migration and angiogenesis, and KPV acts as a powerful NF-κB pathway inhibitor to suppress inflammatory gene transcription. Ideal for users dealing with chronic inflammation, IBD, autoimmune flares, or those seeking the GLOW benefits plus advanced immune modulation. |
| Dose in studies | 2.3 mg. May vary by formulation – dose based on total vial content and supplier guidelines. | 2 mg. Can Vary by formulation – dose based on total vial content and supplier guidelines |
| Frequency | Daily subcutaneous injection (per supplier protocol) | Daily subcutaneous injection (per supplier protocol) |
| Half-life | Blend half-life varies by component (1-4 hours). Designed for once-daily injection as a pre-mixed formulation. | Blend half-life varies by component (1-4 hours). Designed for once-daily injection as a pre-mixed formulation. |
| Cycle length | 8-12 weeks on, 4 weeks off | 12-16 weeks on, 4-6 weeks off. Can extend under medical supervision for chronic conditions. |
| Research level | 2/5 – Limited research | 2/5 – Limited research |
GLOW (GHK-Cu + TB-500 + BPC-157): full profile · KLOW (BPC-157 + GHK-Cu + TB-500 + KPV): full profile
Values from research literature – not medical advice.